in participants without a history of vascular disease, statins reduced the risks of vascular (rr per 1·0 mmol/l ldl cholesterol reduction 0·85, 95% ci 0·77–0·95) and all-cause mortality (rr 0·91, 95% ci 0·85–0·97), and the proportional reductions were similar by baseline risk.